Patient Guides
Plain-language answers to the most common glp1-ozempic questions — written by the Haute MD editorial team.
Ozempic and Wegovy both contain semaglutide but at different doses for different indications. Learn the differences, which is right for you, and how insurance affects access.
Read GuideMost patients regain 50-70% of lost weight within a year of stopping GLP-1 medications. Learn why this happens and what strategies reduce regain.
Read GuideCompounded semaglutide offered the same active ingredient at a fraction of the cost during the FDA shortage. Learn the current status, what changed, and the risks.
Read GuideGLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) produce 15-22% body weight loss. Learn how they work and who qualifies.
Read GuideMedical weight loss uses prescription medications, metabolic evaluation, and physician oversight to achieve sustainable fat loss. Learn how it differs from diet programs.
Read GuideInsulin resistance makes weight loss harder and drives fat storage — especially around the abdomen. Learn how to identify it and what to do about it.
Read GuideVO2 max and muscle mass are the strongest exercise-related predictors of longevity. Learn which types of exercise produce the greatest lifespan benefits.
Read GuideBody contouring removes stubborn fat and tightens skin through surgical (liposuction, tummy tuck) or non-surgical (CoolSculpting, Emsculpt) methods. Learn which is right for you.
Read Guide